APA (7th ed.) Citation

U, O., D, I., O, K., S, O., YE, A., G, A., . . . N, T. (2025). Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study. Journal of personalized medicine, 16(1), . https://doi.org/10.3390/jpm16010008

Chicago Style (17th ed.) Citation

U, Ozkerim, et al. "Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study." Journal of Personalized Medicine 16, no. 1 (2025). https://doi.org/10.3390/jpm16010008.

MLA (9th ed.) Citation

U, Ozkerim, et al. "Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study." Journal of Personalized Medicine, vol. 16, no. 1, 2025, https://doi.org/10.3390/jpm16010008.